These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7733837)

  • 1. A treatment for ataxia.
    Currier RD
    Arch Neurol; 1995 May; 52(5):449. PubMed ID: 7733837
    [No Abstract]   [Full Text] [Related]  

  • 2. Myoclonus, ataxia, and hypoventilation: response to L-5-hydroxytryptophan.
    Feit H; Kirkpatrick J; Van Woert MH; Pandian G
    Neurology; 1983 Jan; 33(1):109-12. PubMed ID: 6600288
    [No Abstract]   [Full Text] [Related]  

  • 3. [Regression of human cerebellar ataxia under long term administration of 5-hydroxytryptophan].
    Trouillas P; Garde A; Robert JM; Adeleine P
    C R Seances Acad Sci III; 1981 Jan; 292(1):119-22. PubMed ID: 6786764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebellar ataxia.
    Klein P
    Arch Neurol; 1989 Nov; 46(11):1166. PubMed ID: 2818245
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of hereditary ataxia with the levorotatory form of hydroxytryptophan.
    Currier RD; Collins GM; Subramony SH; Haerer AF
    Arch Neurol; 1995 May; 52(5):440-1. PubMed ID: 7733833
    [No Abstract]   [Full Text] [Related]  

  • 6. Double-blind crossover study with levorotatory form of hydroxytryptophan in patients with degenerative cerebellar diseases.
    Wessel K; Hermsdörfer J; Deger K; Herzog T; Huss GP; Kömpf D; Mai N; Schimrigk K; Wittkämper A; Ziegler W
    Arch Neurol; 1995 May; 52(5):451-5. PubMed ID: 7733838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myoclonus and L-5-hydroxytryptophan (L-5HTP).
    Van Woert MH
    Prog Clin Biol Res; 1983; 127():43-52. PubMed ID: 6351100
    [No Abstract]   [Full Text] [Related]  

  • 8. [New therapeutic possibilities in depression: 5-hydroxytryptophan].
    López-Ibor Aliño JJ; Ayuso Gutiérrez JL; Montejo Iglesias ML
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1975; 3(3):151-62. PubMed ID: 1099879
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of fast single-joint and multijoint movements in cerebellar cortical atrophy: failure of L-hydroxytryptophan to improve cerebellar ataxia.
    Manto M; Hildebrand J; Godaux E; Roland H; Blum S; Jacquy J
    Arch Neurol; 1997 Oct; 54(10):1192-4. PubMed ID: 9341562
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of 5-hydroxytryptophan, a serotonin precursor, on sleep disorders].
    Soulairac A; Lambinet H
    Ann Med Psychol (Paris); 1977 May; 1(5):792-8. PubMed ID: 339807
    [No Abstract]   [Full Text] [Related]  

  • 11. 5-Hydroxytryptophan: a review of its antidepressant efficacy and adverse effects.
    Byerley WF; Judd LL; Reimherr FW; Grosser BI
    J Clin Psychopharmacol; 1987 Jun; 7(3):127-37. PubMed ID: 3298325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levorotatory form of 5-hydroxytryptophan in Friedreich's ataxia. Results of a double-blind drug-placebo cooperative study.
    Trouillas P; Serratrice G; Laplane D; Rascol A; Augustin P; Barroche G; Clanet M; Degos CF; Desnuelle C; Dumas R
    Arch Neurol; 1995 May; 52(5):456-60. PubMed ID: 7733839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tryptophan and 5-hydroxy-tryptophan in the treatment of depressions].
    Ayuso Guitiérrez JL; Saiz Ruiz J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1977; 5(6):329-34. PubMed ID: 341661
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of the serotonin precursor, 5-hydroxy-tryptophan, on aggressive symptomology].
    Soulairac A; Lambinet H; Aymard N
    Ann Med Psychol (Paris); 1976 Oct; 2(3):459-63. PubMed ID: 798508
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness of 5 hydroxy-tryptophan in Parkinson's disease].
    Bastard J; Truelle JL; Emile J
    Nouv Presse Med; 1976 Sep; 5(29):1836-7. PubMed ID: 787922
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-blind clinical trial of 5-hydroxytryptophan in a case of Lesch-Nyhan syndrome.
    Frith CD; Johnston EC; Joseph MH; Powell RJ; Watts RW
    J Neurol Neurosurg Psychiatry; 1976 Jul; 39(7):656-62. PubMed ID: 792398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease. Modification by 5-hydroxytryptophan.
    Chase TN; Ng LK; Watanabe AM
    Neurology; 1972 May; 22(5):479-84. PubMed ID: 4563493
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome.
    Caruso I; Sarzi Puttini P; Cazzola M; Azzolini V
    J Int Med Res; 1990; 18(3):201-9. PubMed ID: 2193835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of depression with an mao inhibitor followed by 5-HTP--an unfinished research project.
    Kline N; Sacks W
    Acta Psychiatr Scand Suppl; 1980; 280():233-41. PubMed ID: 6996430
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonin precursors in migraine prophylaxis.
    Bono G; Criscuoli M; Martignoni E; Salmon S; Nappi G
    Adv Neurol; 1982; 33():357-63. PubMed ID: 7034490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.